Skip to content

Clinical trials

Phase 1 Pancreatic Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1 Country / region: Germany Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20072
20113
20152
20162
20171
20202
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated6
Unknown status3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Amgen2
Array Biopharma, now a wholly owned subsidiary of Pfizer1
AstraZeneca1
Boehringer Ingelheim1
Celgene1
Eli Lilly and Company1
German Cancer Research Center1
Isarna Therapeutics GmbH1
PD Dr. med. Volker Heinemann1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms18
Colorectal Neoplasms7
Cholangiocarcinoma3
Colonic Neoplasms3
Lung Neoplasms3
Melanoma3
Neoplasms3
Ovarian Neoplasms3
Stomach Neoplasms3
Breast Neoplasms2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.